I
PRCT icon

InceptionR’s Procept Biorobotics PRCT Stock Holding History

InceptionR’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,048
Closed -$226K – 870
2026
Q1 		$226K Sell
9,048
-5,174
-36% -$146K 0.05% 549
2025
Q4 		$447K Buy
14,222
+8,294
+140% +$275K 0.12% 308
2025
Q3 		$212K Buy
+5,928
New +$271K 0.05% 593

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

InceptionR's PRCT Position: Q2 2026 in Review

InceptionR sold out of Procept Biorobotics (PRCT) in Q2 2026, closing a stake of 9,048 shares — an estimated $226K sold.

InceptionR first reported a position in PRCT in Q3 2025 and held it in 3 quarters. The position peaked at $447K in Q4 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • InceptionR reported no remaining Procept Biorobotics position as of Q2 2026 after selling out during the quarter.
  • InceptionR sold 9,048 Procept Biorobotics shares in Q2 2026, an estimated $226K.
  • InceptionR first reported a position in Procept Biorobotics in Q3 2025 and held it in 3 quarters.
  • InceptionR's Procept Biorobotics position peaked at $447K in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.